Sichuan Hebang Biotechnology Corporation Limited (SHA:603077)
China flag China · Delayed Price · Currency is CNY
2.530
+0.020 (0.80%)
May 28, 2026, 3:00 PM CST

SHA:603077 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
6,8166,6996,9993,0644,5911,711
Trading Asset Securities
-----56.89
Cash & Short-Term Investments
6,8166,6996,9993,0644,5911,768
Cash Growth
-4.28%-4.29%128.43%-33.26%159.70%109.01%
Accounts Receivable
1,0271,0102,0432,0492,5681,656
Other Receivables
39.4124.0730.0734.3523.0919.55
Receivables
1,0661,0342,0732,0842,5911,675
Inventory
4,2113,9094,5454,4032,076912.2
Other Current Assets
376.74381.62385.99303.87460.25287.84
Total Current Assets
12,47012,02414,0039,8559,7194,643
Property, Plant & Equipment
9,4369,5419,9529,6849,4838,295
Long-Term Investments
885.33892.36857.45667.27677.37661.99
Goodwill
1,7781,7781,8381,8381,8381,904
Other Intangible Assets
2,8372,8502,3892,2002,1431,967
Long-Term Deferred Tax Assets
133.93145.9127.2350.38110.325.83
Long-Term Deferred Charges
286.54232.38174.48105.4634.017.29
Other Long-Term Assets
892.58745.54308.09142.1697.84417.19
Total Assets
28,71928,20929,65024,54224,10317,922
Accounts Payable
801.48930.522,1081,8771,8771,156
Accrued Expenses
53.1596.5276.21103.0191.37126.24
Short-Term Debt
1,3292,3082,3531,1681,2221,171
Current Portion of Long-Term Debt
781.58260.08745.33342.3216495
Current Portion of Leases
-14.135.972.442.44-
Current Income Taxes Payable
55.6813.7714.8755.0195.71140.79
Current Unearned Revenue
194.52139.2349.5596.6235.07371.54
Other Current Liabilities
20.0221.8821.725.4346.562.07
Total Current Liabilities
3,2353,7845,3753,6703,7343,123
Long-Term Debt
6,9436,1094,936431.17408.4868.09
Long-Term Leases
20.5921.9614.5224.9421.5437.06
Long-Term Unearned Revenue
144.76145.15130.1775.2579.0316.79
Long-Term Deferred Tax Liabilities
181.62173.78187.92122.7596.0239.99
Other Long-Term Liabilities
12.5216.15----
Total Liabilities
10,53710,25110,6434,3244,3393,285
Common Stock
8,8328,8328,8318,8318,8318,831
Additional Paid-In Capital
980.93950.181,0351,1251,095470.46
Retained Earnings
9,7209,54610,07810,2049,3135,642
Treasury Stock
-1,749-1,790-1,697-650.37-150-700
Comprehensive Income & Other
318.64338.56379.1566.429.451.9
Total Common Equity
18,10217,87718,62619,57519,11814,245
Minority Interest
79.3881.91380.13643.04644.86391.84
Shareholders' Equity
18,18217,95919,00720,21819,76314,637
Total Liabilities & Equity
28,71928,20929,65024,54224,10317,922
Total Debt
9,0748,7148,0551,9691,8181,372
Net Cash (Debt)
-2,258-2,015-1,0561,0962,773396.4
Net Cash Growth
----60.49%599.57%-
Net Cash Per Share
-0.28-0.25-0.120.130.320.05
Filing Date Shares Outstanding
7,9977,9748,0228,5128,7258,394
Total Common Shares Outstanding
7,9977,9748,0228,5128,7258,394
Working Capital
9,2358,2408,6296,1855,9851,520
Book Value Per Share
2.262.242.322.302.191.70
Tangible Book Value
13,48713,24914,39915,53715,13710,374
Tangible Book Value Per Share
1.691.661.791.831.731.24
Buildings
-4,1343,7663,5642,856-
Machinery
-11,63811,30311,67710,357-
Construction In Progress
-2,1362,3541,1741,885-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.